MENU
ELDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Eledon Pharmaceuticals (ELDN) Ownership - Who owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis... Show more

Profile

Industry
Pharmaceuticals Major
Address
19800 MacArthur Boulevard
Phone
+1 949 238-8090
Employees
33
Web
https://www.eledon.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
293.31M
P/E Ratio
2.71
Total Cash
111.09M
Projected Growth
N/A
Total Debt
555K
Revenue
N/A
Risk (Beta)
-0.34
Dividend Yield
N/A
Total Cash/Share
1.44
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
ELDN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
19800 MacArthur Boulevard
Phone
+1 949 238-8090
Employees
33
Web
https://www.eledon.com